{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T19:45:53Z","timestamp":1787946353060,"version":"build-2784847793"},"reference-count":101,"publisher":"The Royal Society","issue":"1957","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Anne Wojcicki Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The human epidermal growth factor receptor (EGFR or HER1) and its three close relatives, HER2, HER3 and HER4, are receptor tyrosine kinases (RTKs) that regulate critical cellular processes and are frequently dysregulated in cancer. In contrast to RTKs that are activated primarily by trans-autophosphorylation, HER family receptors switch on through a fundamentally different mechanism based on asymmetric interactions between two kinase domains within a dimer. This distinctive mode of allosteric activation arose early in evolution and remains unique to the HER family. This review describes how ligand binding promotes asymmetric dimerization of the EGFR kinase domains, whereby one kinase (the \u2018activator\u2019) allosterically stabilizes the active conformation of its partner (the \u2018receiver\u2019) without requiring activation loop phosphorylation. Structural elements that enable this process include a hydrophobic activator\/receiver interface, a membrane-proximal juxtamembrane \u2018latch\u2019 that stabilizes the dimer and an autoinhibitory element in the C-terminal tail that favours the inactive state. We discuss how oncogenic alterations, including the L858R mutation, exon 19 deletions and kinase domain duplications, drive ligand-independent asymmetric dimerization and how the action of the endogenous inhibitor MIG-6 and new allosteric inhibitors can be understood in the context of activator\/receiver asymmetric dimerization.<\/jats:p>\n                  <jats:p>This article is part of the discussion meeting issue \u2018Epidermal growth factor receptor after 40 years\u2019.<\/jats:p>","DOI":"10.1098\/rstb.2024.0502","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T07:09:21Z","timestamp":1787814561000},"source":"Crossref","is-referenced-by-count":1,"title":["Asymmetric dimerization and allosteric control in the epidermal growth factor receptor"],"prefix":"10.1098","volume":"381","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1168-6111","authenticated-orcid":false,"given":"Yongjian","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Vanderbilt University School of Medicine 1 , Nashville, TN 37235, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4812-4171","authenticated-orcid":false,"given":"Timothy J.","family":"Eisen","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Vanderbilt University School of Medicine 1 , Nashville, TN 37235, USA"},{"name":"California Institute for Quantitative Biosciences, University of California, Berkeley 2 , Berkeley, CA 94720, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arathi","family":"Nair","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Vanderbilt University School of Medicine 1 , Nashville, TN 37235, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Muratcioglu","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Vanderbilt University School of Medicine 1 , Nashville, TN 37235, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kuriyan","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Vanderbilt University School of Medicine 1 , Nashville, TN 37235, USA"},{"name":"Department of Cell and Developmental Biology, Vanderbilt University 3 , Nashville, TN, USA"},{"name":"Department of Chemistry, Vanderbilt University 4 , Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"175","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"2026082703091554200_RSTB20240502C1","doi-asserted-by":"crossref","first-page":"a020768","DOI":"10.1101\/cshperspect.a020768","article-title":"The EGFR family: not so prototypical receptor tyrosine kinases","volume":"6","author":"Lemmon","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"2026082703091554200_RSTB20240502C2","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","article-title":"Cell signaling by receptor tyrosine kinases","volume":"141","author":"Lemmon","year":"2010","journal-title":"Cell"},{"key":"2026082703091554200_RSTB20240502C3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/35052073","article-title":"Untangling the ErbB signalling network","volume":"2","author":"Yarden","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2026082703091554200_RSTB20240502C4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrc1609","article-title":"ERBB receptors and cancer: the complexity of targeted inhibitors","volume":"5","author":"Hynes","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"2026082703091554200_RSTB20240502C5","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ccr.2014.02.025","article-title":"ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics","volume":"25","author":"Arteaga","year":"2014","journal-title":"Cancer Cell"},{"key":"2026082703091554200_RSTB20240502C6","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.cell.2006.05.013","article-title":"An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor","volume":"125","author":"Zhang","year":"2006","journal-title":"Cell"},{"key":"2026082703091554200_RSTB20240502C7","doi-asserted-by":"crossref","first-page":"31461","DOI":"10.1074\/jbc.C300186200","article-title":"Structure of a c-kit product complex reveals the basis for kinase transactivation","volume":"278","author":"Mol","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2026082703091554200_RSTB20240502C8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10059-010-0080-5","article-title":"Asymmetric tyrosine kinase arrangements in activation or autophosphorylation of receptor tyrosine kinases","volume":"29","author":"Bae","year":"2010","journal-title":"Mol. Cells"},{"key":"2026082703091554200_RSTB20240502C9","doi-asserted-by":"crossref","first-page":"21608","DOI":"10.1073\/pnas.0912101106","article-title":"Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3","volume":"106","author":"Jura","year":"2009","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026082703091554200_RSTB20240502C10","doi-asserted-by":"crossref","first-page":"7692","DOI":"10.1073\/pnas.1002753107","article-title":"ErbB3\/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation","volume":"107","author":"Shi","year":"2010","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026082703091554200_RSTB20240502C11","doi-asserted-by":"crossref","first-page":"eaav3810","DOI":"10.1126\/scisignal.aav3810","article-title":"Tracing the origin and evolution of pseudokinases across the tree of life","volume":"12","author":"Kwon","year":"2019","journal-title":"Sci. Signal."},{"key":"2026082703091554200_RSTB20240502C12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0014-4827(02)00101-5","article-title":"The deaf and the dumb: the biology of ErbB-2 and ErbB-3","volume":"284","author":"Citri","year":"2003","journal-title":"Exp. Cell Res."},{"key":"2026082703091554200_RSTB20240502C13","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cell.2012.02.063","article-title":"Oncogenic mutations counteract intrinsic disorder in the EGFR kinase and promote receptor dimerization","volume":"149","author":"Shan","year":"2012","journal-title":"Cell"},{"key":"2026082703091554200_RSTB20240502C14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molcel.2011.03.004","article-title":"Catalytic control in the EGF receptor and its connection to general kinase regulatory mechanisms","volume":"42","author":"Jura","year":"2011","journal-title":"Mol. Cell"},{"key":"2026082703091554200_RSTB20240502C15","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1056\/NEJMra0707704","article-title":"EGFR antagonists in cancer treatment","volume":"358","author":"Ciardiello","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"2026082703091554200_RSTB20240502C16","first-page":"1002","article-title":"Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies","volume":"44","author":"Masui","year":"1984","journal-title":"Cancer Res."},{"key":"2026082703091554200_RSTB20240502C17","first-page":"5749","article-title":"ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy","volume":"62","author":"Wakeling","year":"2002","journal-title":"Cancer Res."},{"key":"2026082703091554200_RSTB20240502C18","first-page":"4838","article-title":"Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase","volume":"57","author":"Moyer","year":"1997","journal-title":"Cancer Res."},{"key":"2026082703091554200_RSTB20240502C19","first-page":"85","article-title":"The effects of the novel, reversible epidermal growth factor receptor\/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo","volume":"1","author":"Rusnak","year":"2001","journal-title":"Mol. Cancer Ther."},{"key":"2026082703091554200_RSTB20240502C20","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1158\/2159-8290.CD-14-0337","article-title":"AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer","volume":"4","author":"Cross","year":"2014","journal-title":"Cancer Discov."},{"key":"2026082703091554200_RSTB20240502C21","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nrc2947","article-title":"Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer","volume":"10","author":"Pao","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"2026082703091554200_RSTB20240502C22","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrclinonc.2014.104","article-title":"Acquired resistance to TKIs in solid tumours: learning from lung cancer","volume":"11","author":"Camidge","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2026082703091554200_RSTB20240502C23","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nm.3854","article-title":"Acquired EGFRC797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFRT790M","volume":"21","author":"Thress","year":"2015","journal-title":"Nat. Med."},{"key":"2026082703091554200_RSTB20240502C24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nbt1358","article-title":"A quantitative analysis of kinase inhibitor selectivity","volume":"26","author":"Karaman","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"2026082703091554200_RSTB20240502C25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nbt1068","article-title":"A small molecule\u2013kinase interaction map for clinical kinase inhibitors","volume":"23","author":"Fabian","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"2026082703091554200_RSTB20240502C26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrc2559","article-title":"Targeting cancer with small molecule kinase inhibitors","volume":"9","author":"Zhang","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"2026082703091554200_RSTB20240502C27","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.drudis.2012.11.009","article-title":"\u03b1C helix displacement as a general approach for allosteric modulation of protein kinases","volume":"18","author":"Palmieri","year":"2013","journal-title":"Drug Discov. Today"},{"key":"2026082703091554200_RSTB20240502C28","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1056\/NEJMoa1902328","article-title":"Asciminib in chronic myeloid leukemia after ABL kinase inhibitor failure","volume":"381","author":"Hughes","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"2026082703091554200_RSTB20240502C29","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nature21702","article-title":"The allosteric inhibitor ABL001 enables dual targeting of BCR\u2013ABL1","volume":"543","author":"Wylie","year":"2017","journal-title":"Nature"},{"key":"2026082703091554200_RSTB20240502C30","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0092-8674(03)00194-6","article-title":"Structural basis for the autoinhibition of c-Abl tyrosine kinase","volume":"112","author":"Nagar","year":"2003","journal-title":"Cell"},{"key":"2026082703091554200_RSTB20240502C31","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","article-title":"Induction of chronic myelogenous leukemia in mice by the P210bcr\/abl gene of the Philadelphia chromosome","volume":"247","author":"Daley","year":"1990","journal-title":"Science"},{"key":"2026082703091554200_RSTB20240502C32","doi-asserted-by":"crossref","first-page":"eadt5931","DOI":"10.1126\/scisignal.adt5931","article-title":"Autophosphorylation of oncoprotein TEL-ABL in myeloid and lymphoid cells confers resistance to the allosteric ABL inhibitor asciminib","volume":"18","author":"Muratcioglu","year":"2025","journal-title":"Sci. Signal."},{"key":"2026082703091554200_RSTB20240502C33","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1073\/pnas.1417811112","article-title":"Discovery of multiple hidden allosteric sites by combining Markov state models and experiments","volume":"112","author":"Bowman","year":"2015","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026082703091554200_RSTB20240502C34","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/nature06526","article-title":"Reaching for high-hanging fruit in drug discovery at protein\u2013protein interfaces","volume":"450","author":"Wells","year":"2007","journal-title":"Nature"},{"key":"2026082703091554200_RSTB20240502C35","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nature12796","article-title":"K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions","volume":"503","author":"Ostrem","year":"2013","journal-title":"Nature"},{"key":"2026082703091554200_RSTB20240502C36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nature17960","article-title":"Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors","volume":"534","author":"Jia","year":"2016","journal-title":"Nature"},{"key":"2026082703091554200_RSTB20240502C37","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s43018-022-00351-8","article-title":"An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancer","volume":"3","author":"To","year":"2022","journal-title":"Nat. Cancer"},{"key":"2026082703091554200_RSTB20240502C38","doi-asserted-by":"crossref","first-page":"9662","DOI":"10.1021\/acs.jmedchem.2c00704","article-title":"Discovery of BLU-945, a reversible, potent, and wild-type-sparing next-generation EGFR mutant inhibitor for treatment-resistant non-small-cell lung cancer","volume":"65","author":"Eno","year":"2022","journal-title":"J. Med. Chem."},{"key":"2026082703091554200_RSTB20240502C39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0092-8674(00)00114-8","article-title":"Cell signaling by receptor tyrosine kinases","volume":"103","author":"Schlessinger","year":"2000","journal-title":"Cell"},{"key":"2026082703091554200_RSTB20240502C40","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/373573a0","article-title":"Protein modules and signalling networks","volume":"373","author":"Pawson","year":"1995","journal-title":"Nature"},{"key":"2026082703091554200_RSTB20240502C41","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.molcel.2004.08.024","article-title":"Regulation of protein kinases; controlling activity through activation segment conformation","volume":"15","author":"Nolen","year":"2004","journal-title":"Mol. Cell"},{"key":"2026082703091554200_RSTB20240502C42","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0092-8674(02)00741-9","article-title":"The conformational plasticity of protein kinases","volume":"109","author":"Huse","year":"2002","journal-title":"Cell"},{"key":"2026082703091554200_RSTB20240502C43","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/372746a0","article-title":"Crystal structure of the tyrosine kinase domain of the human insulin receptor","volume":"372","author":"Hubbard","year":"1994","journal-title":"Nature"},{"key":"2026082703091554200_RSTB20240502C44","doi-asserted-by":"crossref","first-page":"a008946","DOI":"10.1101\/cshperspect.a008946","article-title":"The insulin receptor: both a prototypical and atypical receptor tyrosine kinase","volume":"5","author":"Hubbard","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"2026082703091554200_RSTB20240502C45","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nature26153","article-title":"Structure of the insulin receptor\u2013insulin complex by single-particle cryo-EM analysis","volume":"556","author":"Scapin","year":"2018","journal-title":"Nature"},{"key":"2026082703091554200_RSTB20240502C46","doi-asserted-by":"crossref","first-page":"e48630","DOI":"10.7554\/eLife.48630","article-title":"Activation mechanism of the insulin receptor revealed by cryo-EM structure of the fully liganded receptor\u2013ligand complex","volume":"8","author":"Uchikawa","year":"2019","journal-title":"eLife"},{"key":"2026082703091554200_RSTB20240502C47","doi-asserted-by":"crossref","first-page":"e201907210","DOI":"10.1083\/jcb.201907210","article-title":"Cryo-EM structure of the complete and ligand-saturated insulin receptor ectodomain","volume":"219","author":"Gutmann","year":"2020","journal-title":"J. Cell Biol."},{"key":"2026082703091554200_RSTB20240502C48","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41580-025-00826-3","article-title":"Regulation and function of insulin and insulin-like growth factor receptor signalling","volume":"26","author":"Choi","year":"2025","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2026082703091554200_RSTB20240502C49","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1083\/jcb.201711047","article-title":"Visualization of ligand-induced transmembrane signaling in the full-length human insulin receptor","volume":"217","author":"Gutmann","year":"2018","journal-title":"J. Cell Biol."},{"key":"2026082703091554200_RSTB20240502C50","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1093\/emboj\/16.18.5572","article-title":"Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog","volume":"16","author":"Hubbard","year":"1997","journal-title":"EMBO J."},{"key":"2026082703091554200_RSTB20240502C51","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/0006-291X(92)90812-Y","article-title":"A highly conserved tyrosine residue at codon 845 within the kinase domain is not required for the transforming activity of human epidermal growth factor receptor","volume":"186","author":"Gotoh","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2026082703091554200_RSTB20240502C52","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.str.2017.12.012","article-title":"Regulation of kinase activity in the Caenorhabditis elegans EGF receptor, LET-23","volume":"26","author":"Liu","year":"2018","journal-title":"Structure"},{"key":"2026082703091554200_RSTB20240502C53","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.celrep.2013.06.025","article-title":"Cracking the molecular origin of intrinsic tyrosine kinase activity through analysis of pathogenic gain-of-function mutations","volume":"4","author":"Chen","year":"2013","journal-title":"Cell Rep."},{"key":"2026082703091554200_RSTB20240502C54","doi-asserted-by":"crossref","first-page":"e1003435","DOI":"10.1371\/journal.pcbi.1003435","article-title":"Coarse-grained molecular simulation of epidermal growth factor receptor protein tyrosine kinase multi-site self-phosphorylation","volume":"10","author":"Koland","year":"2014","journal-title":"PLoS Comput. Biol."},{"key":"2026082703091554200_RSTB20240502C55","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1128\/MCB.00248-15","article-title":"Analysis of the role of the C-terminal tail in the regulation of the epidermal growth factor receptor","volume":"35","author":"Kovacs","year":"2015","journal-title":"Mol. Cell. Biol."},{"key":"2026082703091554200_RSTB20240502C56","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0092-8674(01)00496-2","article-title":"Structural basis for autoinhibition of the EphB2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region","volume":"106","author":"Wybenga-Groot","year":"2001","journal-title":"Cell"},{"key":"2026082703091554200_RSTB20240502C57","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1097-2765(01)00332-X","article-title":"The TGF\u03b2 receptor activation process: an inhibitor- to substrate-binding switch","volume":"8","author":"Huse","year":"2001","journal-title":"Mol. Cell"},{"key":"2026082703091554200_RSTB20240502C58","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0092-8674(00)80555-3","article-title":"Crystal structure of the cytoplasmic domain of the type I TGF \u03b2 receptor in complex with FKBP12","volume":"96","author":"Huse","year":"1999","journal-title":"Cell"},{"key":"2026082703091554200_RSTB20240502C59","doi-asserted-by":"crossref","first-page":"46265","DOI":"10.1074\/jbc.M207135200","article-title":"Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor","volume":"277","author":"Stamos","year":"2002","journal-title":"J. Biol. Chem."},{"key":"2026082703091554200_RSTB20240502C60","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.1158\/0008-5472.CAN-04-1168","article-title":"A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells","volume":"64","author":"Wood","year":"2004","journal-title":"Cancer Res."},{"key":"2026082703091554200_RSTB20240502C61","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/376313a0","article-title":"Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex","volume":"376","author":"Jeffrey","year":"1995","journal-title":"Nature"},{"key":"2026082703091554200_RSTB20240502C62","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1021\/bi9614141","article-title":"A model for the activation of the epidermal growth factor receptor kinase involvement of an asymmetric dimer?","volume":"36","author":"Groenen","year":"1997","journal-title":"Biochemistry"},{"key":"2026082703091554200_RSTB20240502C63","doi-asserted-by":"crossref","first-page":"19238","DOI":"10.1073\/pnas.0703854104","article-title":"Epidermal growth factor receptor juxtamembrane region regulates allosteric tyrosine kinase activation","volume":"104","author":"Thiel","year":"2007","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026082703091554200_RSTB20240502C64","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.cell.2009.04.025","article-title":"Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment","volume":"137","author":"Jura","year":"2009","journal-title":"Cell"},{"key":"2026082703091554200_RSTB20240502C65","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.molcel.2009.04.034","article-title":"The juxtamembrane region of the EGF receptor functions as an activation domain","volume":"34","author":"Red Brewer","year":"2009","journal-title":"Mol. Cell"},{"key":"2026082703091554200_RSTB20240502C66","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1073\/pnas.0708281105","article-title":"6-Ethynylthieno[3,2-d]- and 6-ethynylthieno[2,3-d]pyrimidin-4-anilines as tunable covalent modifiers of ErbB kinases","volume":"105","author":"Wood","year":"2008","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026082703091554200_RSTB20240502C67","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.cell.2012.12.032","article-title":"Conformational coupling across the plasma membrane in activation of the EGF receptor","volume":"152","author":"Endres","year":"2013","journal-title":"Cell"},{"key":"2026082703091554200_RSTB20240502C68","doi-asserted-by":"crossref","first-page":"6950","DOI":"10.1074\/jbc.M709202200","article-title":"Spatial structure of the dimeric transmembrane domain of the growth factor receptor ErbB2 presumably corresponding to the receptor active state","volume":"283","author":"Bocharov","year":"2008","journal-title":"J. Biol. Chem."},{"key":"2026082703091554200_RSTB20240502C69","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.bbamem.2016.02.023","article-title":"Alternative packing of EGFR transmembrane domain suggests that protein\u2013lipid interactions underlie signal conduction across membrane","volume":"1858","author":"Bocharov","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"2026082703091554200_RSTB20240502C70","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1021\/acs.biochem.6b01085","article-title":"The conformation of the epidermal growth factor receptor transmembrane domain dimer dynamically adapts to the local membrane environment","volume":"56","author":"Bocharov","year":"2017","journal-title":"Biochemistry"},{"key":"2026082703091554200_RSTB20240502C71","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.cell.2012.12.030","article-title":"Architecture and membrane interactions of the EGF receptor","volume":"152","author":"Arkhipov","year":"2013","journal-title":"Cell"},{"key":"2026082703091554200_RSTB20240502C72","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1021\/cb300216f","article-title":"Bipartite tetracysteine display reveals allosteric control of ligand-specific EGFR activation","volume":"7","author":"Scheck","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"2026082703091554200_RSTB20240502C73","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/nsmb.2168","article-title":"Mechanistic insights into the activation of oncogenic forms of EGF receptor","volume":"18","author":"Wang","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2026082703091554200_RSTB20240502C74","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1038\/s41467-022-34398-z","article-title":"Biochemical and structural basis for differential inhibitor sensitivity of EGFR with distinct exon 19 mutations","volume":"13","author":"van Alderwerelt van Rosenburgh","year":"2022","journal-title":"Nat. Commun."},{"key":"2026082703091554200_RSTB20240502C75","doi-asserted-by":"crossref","first-page":"e2206588119","DOI":"10.1073\/pnas.2206588119","article-title":"Allele-specific activation, enzyme kinetics, and inhibitor sensitivities of EGFR exon 19 deletion mutations in lung cancer","volume":"119","author":"Brown","year":"2022","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026082703091554200_RSTB20240502C76","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ccr.2006.12.017","article-title":"Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity","volume":"11","author":"Yun","year":"2007","journal-title":"Cancer Cell"},{"key":"2026082703091554200_RSTB20240502C77","doi-asserted-by":"crossref","first-page":"E3595","DOI":"10.1073\/pnas.1220050110","article-title":"Mechanism for activation of mutated epidermal growth factor receptors in lung cancer","volume":"110","author":"Red Brewer","year":"2013","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026082703091554200_RSTB20240502C78","doi-asserted-by":"crossref","first-page":"e313","DOI":"10.1371\/journal.pmed.0020313","article-title":"Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants","volume":"2","author":"Greulich","year":"2005","journal-title":"PLoS Med."},{"key":"2026082703091554200_RSTB20240502C79","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1056\/NEJMoa044238","article-title":"EGFR mutation and resistance of non-small-cell lung cancer to gefitinib","volume":"352","author":"Kobayashi","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"2026082703091554200_RSTB20240502C80","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1073\/pnas.0709662105","article-title":"The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP","volume":"105","author":"Yun","year":"2008","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026082703091554200_RSTB20240502C81","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1158\/2159-8290.CD-15-0654","article-title":"EGFR kinase domain duplication (EGFR-KDD) is a novel oncogenic driver in lung cancer that is clinically responsive to Afatinib","volume":"5","author":"Gallant","year":"2015","journal-title":"Cancer Discov."},{"key":"2026082703091554200_RSTB20240502C82","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/s41467-021-21613-6","article-title":"Structure\u2013function analysis of oncogenic EGFR Kinase Domain Duplication reveals insights into activation and a potential approach for therapeutic targeting","volume":"12","author":"Du","year":"2021","journal-title":"Nat. Commun."},{"key":"2026082703091554200_RSTB20240502C83","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.str.2025.11.017","article-title":"The role of kinase domain dimerization in EGFR activation","volume":"34","author":"Petrova","year":"2026","journal-title":"Structure"},{"key":"2026082703091554200_RSTB20240502C84","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.1128\/MCB.20.20.7735-7750.2000","article-title":"Inhibition of ErbB-2 mitogenic and transforming activity by RALT, a mitogen-induced signal transducer which binds to the ErbB-2 kinase domain","volume":"20","author":"Fiorentino","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"2026082703091554200_RSTB20240502C85","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1515\/BC.2001.200","article-title":"Mig-6 is a negative regulator of the epidermal growth factor receptor signal","volume":"382","author":"Hackel","year":"2001","journal-title":"Biol. Chem."},{"key":"2026082703091554200_RSTB20240502C86","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.1073\/pnas.0914930107","article-title":"Mig-6 controls EGFR trafficking and suppresses gliomagenesis","volume":"107","author":"Ying","year":"2010","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026082703091554200_RSTB20240502C87","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nature05998","article-title":"Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface","volume":"450","author":"Zhang","year":"2007","journal-title":"Nature"},{"key":"2026082703091554200_RSTB20240502C88","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nsmb.3074","article-title":"Structure and mechanism of activity-based inhibition of the EGF receptor by Mig6","volume":"22","author":"Park","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2026082703091554200_RSTB20240502C89","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1158\/2159-8290.CD-18-0903","article-title":"Single and dual targeting of mutant EGFR with an allosteric inhibitor","volume":"9","author":"To","year":"2019","journal-title":"Cancer Discov."},{"key":"2026082703091554200_RSTB20240502C90","doi-asserted-by":"crossref","first-page":"e70455","DOI":"10.1002\/pro.70455","article-title":"Conformational dynamics in insulin receptor kinase reveal a type III allosteric pocket","volume":"35","author":"Verma","year":"2026","journal-title":"Protein Sci."},{"key":"2026082703091554200_RSTB20240502C91","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1158\/1078-0432.CCR-10-2200","article-title":"GSK1120212 (JTP-74057) is an inhibitor of MEK activity and activation with favorable pharmacokinetic properties for sustained in vivo pathway inhibition","volume":"17","author":"Gilmartin","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"2026082703091554200_RSTB20240502C92","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.tips.2015.04.005","article-title":"FDA-approved small-molecule kinase inhibitors","volume":"36","author":"Wu","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"2026082703091554200_RSTB20240502C93","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.bmc.2017.08.051","article-title":"Conformationally constrained peptides target the allosteric kinase dimer interface and inhibit EGFR activation","volume":"26","author":"Fulton","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"2026082703091554200_RSTB20240502C94","doi-asserted-by":"crossref","first-page":"28071","DOI":"10.1038\/srep28071","article-title":"Evolution of the EGFR pathway in Metazoa and its diversification in the planarian Schmidtea mediterranea","volume":"6","author":"Barber\u00e1n","year":"2016","journal-title":"Sci. Rep."},{"key":"2026082703091554200_RSTB20240502C95","doi-asserted-by":"crossref","first-page":"ra35","DOI":"10.1126\/scisignal.2002733","article-title":"Genomic survey of premetazoans shows deep conservation of cytoplasmic tyrosine kinases and multiple radiations of receptor tyrosine kinases","volume":"5","author":"Suga","year":"2012","journal-title":"Sci. Signal."},{"key":"2026082703091554200_RSTB20240502C96","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"2026082703091554200_RSTB20240502C97","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1021\/bi700002b","article-title":"Unligated epidermal growth factor receptor forms higher order oligomers within microclusters on A431 cells that are sensitive to tyrosine kinase inhibitor binding","volume":"46","author":"Clayton","year":"2007","journal-title":"Biochemistry"},{"key":"2026082703091554200_RSTB20240502C98","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1080\/08977190802442187","article-title":"Predominance of activated EGFR higher-order oligomers on the cell surface","volume":"26","author":"Clayton","year":"2008","journal-title":"Growth Factors"},{"key":"2026082703091554200_RSTB20240502C99","doi-asserted-by":"crossref","first-page":"e14107","DOI":"10.7554\/eLife.14107","article-title":"Molecular basis for multimerization in the activation of the epidermal growth factor receptor","volume":"5","author":"Huang","year":"2016","journal-title":"eLife"},{"key":"2026082703091554200_RSTB20240502C100","doi-asserted-by":"crossref","first-page":"13307","DOI":"10.1038\/ncomms13307","article-title":"EGFR oligomerization organizes kinase-active dimers into competent signalling platforms","volume":"7","author":"Needham","year":"2016","journal-title":"Nat. Commun."},{"key":"2026082703091554200_RSTB20240502C101","doi-asserted-by":"crossref","first-page":"113603","DOI":"10.1016\/j.celrep.2023.113603","article-title":"Distinct interactions stabilize EGFR dimers and higher-order oligomers in cell membranes","volume":"43","author":"Mudumbi","year":"2024","journal-title":"Cell Rep."}],"container-title":["Philosophical Transactions of the Royal Society B: Biological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/royalsocietypublishing.org\/rstb\/article-pdf\/doi\/10.1098\/rstb.2024.0502\/6162297\/rstb.2024.0502.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/royalsocietypublishing.org\/rstb\/article-pdf\/doi\/10.1098\/rstb.2024.0502\/6162297\/rstb.2024.0502.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T07:09:32Z","timestamp":1787814572000},"score":1,"resource":{"primary":{"URL":"https:\/\/royalsocietypublishing.org\/rstb\/article\/381\/1957\/20240502\/483097\/Asymmetric-dimerization-and-allosteric-control-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":101,"journal-issue":{"issue":"1957","published-online":{"date-parts":[[2026,8,27]]},"published-print":{"date-parts":[[2026,8,27]]}},"URL":"https:\/\/doi.org\/10.1098\/rstb.2024.0502","relation":{},"ISSN":["0962-8436","1471-2970"],"issn-type":[{"value":"0962-8436","type":"print"},{"value":"1471-2970","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"article-number":"20240502"}}